182 related articles for article (PubMed ID: 19852789)
1. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results.
Adams JB; Baral M; Geis E; Mitchell J; Ingram J; Hensley A; Zappia I; Newmark S; Gehn E; Rubin RA; Mitchell K; Bradstreet J; El-Dahr J
BMC Clin Pharmacol; 2009 Oct; 9():16. PubMed ID: 19852789
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results.
Adams JB; Baral M; Geis E; Mitchell J; Ingram J; Hensley A; Zappia I; Newmark S; Gehn E; Rubin RA; Mitchell K; Bradstreet J; El-Dahr J
BMC Clin Pharmacol; 2009 Oct; 9():17. PubMed ID: 19852790
[TBL] [Abstract][Full Text] [Related]
3. Chelation for autism spectrum disorder (ASD).
James S; Stevenson SW; Silove N; Williams K
Cochrane Database Syst Rev; 2015 May; (5):CD010766. PubMed ID: 26106752
[TBL] [Abstract][Full Text] [Related]
4. 24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls, a pilot study.
Soden SE; Lowry JA; Garrison CB; Wasserman GS
Clin Toxicol (Phila); 2007; 45(5):476-81. PubMed ID: 17503250
[TBL] [Abstract][Full Text] [Related]
5. Autism: a form of lead and mercury toxicity.
Yassa HA
Environ Toxicol Pharmacol; 2014 Nov; 38(3):1016-24. PubMed ID: 25461563
[TBL] [Abstract][Full Text] [Related]
6. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.
Glotzer DE
Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892
[TBL] [Abstract][Full Text] [Related]
7. DMSA administration to patients with alleged mercury poisoning from dental amalgams: a placebo-controlled study.
Sandborgh Englund G; Dahlqvist R; Lindelöf B; Söderman E; Jonzon B; Vesterberg O; Larsson KS
J Dent Res; 1994 Mar; 73(3):620-8. PubMed ID: 8163732
[TBL] [Abstract][Full Text] [Related]
8. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
Bradberry S; Sheehan T; Vale A
QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
[TBL] [Abstract][Full Text] [Related]
9. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.
Nataf R; Skorupka C; Amet L; Lam A; Springbett A; Lathe R
Toxicol Appl Pharmacol; 2006 Jul; 214(2):99-108. PubMed ID: 16782144
[TBL] [Abstract][Full Text] [Related]
10. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.
Aposhian HV; Maiorino RM; Dart RC; Perry DF
Clin Pharmacol Ther; 1989 May; 45(5):520-6. PubMed ID: 2541962
[TBL] [Abstract][Full Text] [Related]
12. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations.
Graziano JH; Lolacono NJ; Meyer P
J Pediatr; 1988 Oct; 113(4):751-7. PubMed ID: 2845043
[TBL] [Abstract][Full Text] [Related]
13. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
[TBL] [Abstract][Full Text] [Related]
14. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
[TBL] [Abstract][Full Text] [Related]
15. Toxicological status of children with autism vs. neurotypical children and the association with autism severity.
Adams JB; Audhya T; McDonough-Means S; Rubin RA; Quig D; Geis E; Gehn E; Loresto M; Mitchell J; Atwood S; Barnhouse S; Lee W
Biol Trace Elem Res; 2013 Feb; 151(2):171-80. PubMed ID: 23192845
[TBL] [Abstract][Full Text] [Related]
16. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
[TBL] [Abstract][Full Text] [Related]
17. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
Besunder JB; Anderson RL; Super DM
Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentrations.
Chisolm JJ
J Toxicol Clin Toxicol; 2000; 38(4):365-75. PubMed ID: 10930052
[TBL] [Abstract][Full Text] [Related]
19. The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels.
Adams JB; Baral M; Geis E; Mitchell J; Ingram J; Hensley A; Zappia I; Newmark S; Gehn E; Rubin RA; Mitchell K; Bradstreet J; El-Dahr JM
J Toxicol; 2009; 2009():532640. PubMed ID: 20107587
[TBL] [Abstract][Full Text] [Related]
20. Urine mercury excretion following meso-dimercaptosuccinic acid challenge in fish eaters.
Ruha AM; Curry SC; Gerkin RD; Caldwell KL; Osterloh JD; Wax PM
Arch Pathol Lab Med; 2009 Jan; 133(1):87-92. PubMed ID: 19123743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
